Global Hemostats and Tissue Sealants Market was valued US$ 2.78 Bn in 2017 and is expected to reach US$ 5.29 Bn by 2026, at a CAGR of 8.37% during a forecast period. Increasing incidence of chronic diseases, the wide range of applications, patient safety & quick recovery, number of surgeries and growing aging population and technology advancements in the healthcare sector is boosting the growth of the market. Moreover, growing awareness about the usage of hemostats and tissue sealants medical devices to avoid thrombosis and other critical post-operative complications, development of healthcare infrastructure and increasing healthcare expenditure is also propelling the growth of global hemostats and tissue sealants market. Hemostat and tissue sealant are used in major surgical operations to control external as well as internal blood flow from vital organs. MI procedures and development of new tissue sealants and hemostats is trending in the global hemostat and tissue sealant market. Stringent regulations, complications and adverse reactions are the major factors restraining the growth of the hemostats and sealants market. Topical hemostat holds the largest market share and is anticipated to grow at the faster pace. Tissue sealants are sub-segmented into synthetic sealants, fibrin sealants, and other natural sealants. Among these, fibrin sealants will witness a rapid expansion during the forecast period. Surgical repair accounts for the highest revenue share in the market. Also, trauma cases in the applications segment are going to grow exponentially during the forecast period. Orthopedic procedures application are anticipated to grow at the fastest rate during the forecast period due to the rising aging population, new demand for natural surgical hemostats, internal tissue sealants & adhesion barriers with advanced technology, development of the product in the developing regions with greater efficiency. Asia-Pacific market is anticipated to be the fastest-growing region for the hemostats and sealants market owing to the increasing government initiatives that promote the use of such medical devices, growing geriatric population and increasing healthcare expenditure. Europe market is expected to grow due to the upsurge in its geriatric population resulting in a higher frequency of surgeries being performed. Key players operating in the global hemostats and tissue sealants market are B. Braun, 3M, Cardinal Health, Cohera Medical, Haemacure, HyperBranch Medical Technology, NeoMend, Smith & Nephew, Teijin Pharma, Tissuemed, Vascular Solutions, Vivostat, Z-Medica, Advanced Medical, Solutions Group, Baxter International, C. R. Bard, Cryolife, CSL Behring, Integra LifeSciences, and Johnson & Johnson.
Scope of Global Hemostats and Tissue Sealants Market:
Global Hemostats and Tissue Sealants Market, by Product Type:
• Topical hemostats • Tissue Sealants • Cyanoacrylate-based tissue adhesives • Adhesion prevention products
Global Hemostats and Tissue Sealants Market, by Application:
• Surgical Repair • Cardiovascular • Neurological • Orthopedic • Urological • General Surgeries • Reconstructive Surgeries • Trauma Cases
Global Hemostats and Tissue Sealants Market, by End-user:
• Hospitals • Ambulatory Surgical Centers • Specialty Clinics
Global Hemostats and Tissue Sealants Market, by Region:
• North America • Europe • Middle East & Africa • Asia Pacific • Latin America
Key Players Operating In Global Hemostats and Tissue Sealants Market:
• B. Braun • 3M • Cardinal Health • Cohera Medical • Haemacure • HyperBranch Medical Technology • NeoMend • Smith & Nephew • Teijin Pharma • Tissuemed • Vascular Solutions • Vivostat • Z-Medica • Advanced Medical Solutions Group • Baxter International • C. R. Bard • Cryolife • CSL Behring • Integra LifeSciences • Johnson & Johnson
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact Us:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH
Email: sales@maximizemarketresearch.com
Contact: +91 9607365656
